view original article
The local filler industry has contributed greatly to exports as it is considered relatively high-quality high-end products not only in the domestic market but also in China and other overseas markets.
However, with the recent trend of spreading manufacturing technologies and distribution of manufacturing technologies becoming easier, competition among large manufacturers to grow bigger has intensified, pushing them into a race to eat their own flesh and bleed, raising concerns that they will now become a "Red ocean market."
In the case of hyaluronic acid raw material filler, which has been leading the Filler market, Korean makers have neglected to develop technology amid fierce price competition. In addition, the latter launches, which are trying to enter the filler market, were more dominant in their attempts to follow the already well-known feeler manufacturing technology rather than compete with the new technology, raising concerns over disrupting the filler market and intensifying recession.
Bio-Plus is drawing attention as it has completed an original HA fillar called MDM filler, which is applied with three innovative high-end technologies to use hyaluronic acid (HA) materials.
While the hyaluronic acid (HA) based on biocompatibility and support for space in the body has been fiercely competing in the market, the filler that is applied with alternative materials (mainly chemical filler with polymer) developed in advanced countries has been positioned as high-priced and permanent-procedure filler. Experts, however, say that safety and dramatic effects are not enough to match the filler made from the raw material.
"This product is being recognized first in foreign markets." said CEO Jung Hyun-kyu of Bio Plus.
"BioPlus’s MDM filler (MBMT + DMCT + MDAP) is evaluated to have innovative improvements in the phenomenon of early extinguishing, which has been cited as a weakness of the Hyaluronic acid filler,, side effects that occur between unknowingly and unknowingly, and the lack of molding sensation felt when creating post-injection shapes."
BioPlus is a manufacturer of hyaluronic acid (HA) filler, which is specifically named MDM filler.
Unlike most HA filers in Korea, DVS, which requires a considerable degree of bio-treatment technology, is adopted as a bridge system, and as a filler that uses HA as a raw material, it also applies a patented microbead manufacturing method, which increases safety, and the necessity of filler is vivid in the nature of the product itself, according to the company.
Based on the strength of these products, BioPlus has already been recognized in overseas markets as the brand name "SkinPlus-Hyal" and "HyalDew" and makes up more than 95 percent of its sales from overseas. Recently, it has been asked by foreign countries to expand overseas plants and is simultaneously pursuing projects to build production bases not only in Asia, but also in the Middle East and Europe, the main home of filler.